AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 2180492 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorambucil at a daily dose of 0.1 mg/kg
Number of subjects: 612
Study 2180492 — intervention group
Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 612
Study 2180492 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorambucil
Number of subjects: 612
Study 2180492 — intervention group
Group type: EXPERIMENTAL
Intervention: Stage A patients with hemoglobin ≥ 120 g/L and lymphocyte count < 30 x 10(9)/L
Number of subjects: 612
Study 6997218 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-dilution hemofiltration
Number of subjects: 14
Study 31200160 — intervention group
Group type: EXPERIMENTAL
Intervention: Real indoor air purification (PM2.5 exposure reduced to 28.3 μg/m3)
Number of subjects: 45
Study 31200160 — intervention group
Group type: COMPARATOR
Intervention: Sham indoor air purification (PM2.5 exposure at 56.9 μg/m3)
Number of subjects: 45
Study 28609276 — intervention group
Group type: EXPERIMENTAL
Intervention: Social oocyte cryopreservation
Number of subjects: 379
Study 28609276 — intervention group
Group type: EXPERIMENTAL
Intervention: Cost barrier to oocyte cryopreservation
Number of subjects: 379
Study 26272704 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-visit treatment
Number of subjects: 538
Study 26272704 — intervention group
Group type: COMPARATOR
Intervention: Multiple-visit treatment
Number of subjects: 538
Study 23808447 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional traffic light system (S-SN)
Number of subjects: 32
Study 23808447 — intervention group
Group type: COMPARATOR
Intervention: Monochrome system (SM)
Number of subjects: 32
Study 21509668 — intervention group
Group type: EXPERIMENTAL
Intervention: Hongyou Ointment and Shengji Powder (CM group)
Number of subjects: 62
Study 21509668 — intervention group
Group type: COMPARATOR
Intervention: Mupirocin ointment, growth factor (bFGF), and Vaseline gauze (WM group)
Number of subjects: 62
Study 21509668 — intervention group
Group type: EXPERIMENTAL
Intervention: CM treatment
Number of subjects: 62
Study 19453580 — intervention group
Group type: EXPERIMENTAL
Intervention: New landmark-guided approach
Number of subjects: 140
Study 19453580 — intervention group
Group type: COMPARATOR
Intervention: Traditional para-carotid approach
Number of subjects: 140
Study 16541934 — intervention group
Group type: EXPERIMENTAL
Intervention: Caloric asymmetry
Number of subjects: 54
Study 16541934 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher age
Number of subjects: 54
Study 15189627 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotional support provided by women
Number of subjects: 79
Study 15189627 — intervention group
Group type: EXPERIMENTAL
Intervention: Agency
Number of subjects: 79
Study 15189627 — intervention group
Group type: EXPERIMENTAL
Intervention: Unmitigated communion
Number of subjects: 79
Study 15189627 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative interactions
Number of subjects: 79
Study 15189627 — intervention group
Group type: EXPERIMENTAL
Intervention: Advice
Number of subjects: 79
Study 11112243 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetaminophen 1000 mg (two 500-mg Extra Strength Tylenol tablets)
Number of subjects: 0
Study 11112243 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 9167744 — intervention group
Group type: EXPERIMENTAL
Intervention: Angiotensin II (AT II) infusion
Number of subjects: 11
Study 9167744 — intervention group
Group type: COMPARATOR
Intervention: Baseline (without AT II infusion)
Number of subjects: 11
Study 8460050 — intervention group
Group type: EXPERIMENTAL
Intervention: Amitriptyline 50 mg p.o. HS on postoperative days 1, 2, and 3
Number of subjects: 28
Study 8460050 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study 3079935 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg/day leuprolide acetate
Number of subjects: 199
Study 3079935 — intervention group
Group type: COMPARATOR
Intervention: 3 mg/day diethylstilbestrol (DES)
Number of subjects: 199
Study 28695457 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative C-peptide testing
Number of subjects: 12
Study 28695457 — intervention group
Group type: COMPARATOR
Intervention: Clinical assessment alone
Number of subjects: 12
Study 28695457 — intervention group
Group type: EXPERIMENTAL
Intervention: Fasting and stimulated C-peptide measurements
Number of subjects: 12
Study 28695457 — intervention group
Group type: EXPERIMENTAL
Intervention: Islet cell antibody testing
Number of subjects: 12
Study 27335114 — intervention group
Group type: EXPERIMENTAL
Intervention: Brivaracetam 50 mg/d
Number of subjects: 1160
Study 27335114 — intervention group
Group type: EXPERIMENTAL
Intervention: Brivaracetam 100 mg/d
Number of subjects: 1160
Study 27335114 — intervention group
Group type: EXPERIMENTAL
Intervention: Brivaracetam 200 mg/d
Number of subjects: 1160
Study 27335114 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1160
Study 24947633 — intervention group
Group type: EXPERIMENTAL
Intervention: Closure of the hernia gap during laparoscopic ventral hernia repair
Number of subjects: 80
Study 24947633 — intervention group
Group type: COMPARATOR
Intervention: Standard laparoscopic ventral hernia repair (non-closure of the gap)
Number of subjects: 80
Study 22079507 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose endotoxin
Number of subjects: 39
Study 22079507 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study 20731495 — intervention group
Group type: EXPERIMENTAL
Intervention: Oregon model of Parent Management Training (PMTO)
Number of subjects: 110
Study 20731495 — intervention group
Group type: COMPARATOR
Intervention: Non-intervention condition
Number of subjects: 110
Study 18685503 — intervention group
Group type: EXPERIMENTAL
Intervention: Symbiotic formulation (Flortec)
Number of subjects: 267
Study 18685503 — intervention group
Group type: COMPARATOR
Intervention: Prebiotic
Number of subjects: 267
Study 18685503 — intervention group
Group type: EXPERIMENTAL
Intervention: Symbiotic formulation (Flortec) in IBS-predominant diarrhea
Number of subjects: 267
Study 16549835 — intervention group
Group type: EXPERIMENTAL
Intervention: Donepezil 5 mg/d for 6 weeks, then 10 mg/d for 18 weeks
Number of subjects: 34
Study 15023160 — intervention group
Group type: EXPERIMENTAL
Intervention: MMF/CNI continuation
Number of subjects: 39
Study 15023160 — intervention group
Group type: COMPARATOR
Intervention: MMF/CNI withdrawal
Number of subjects: 39
Study 11697809 — intervention group
Group type: EXPERIMENTAL
Intervention: Raloxifene 60 mg/day for 6 months
Number of subjects: 50
Study 11697809 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 9386022 — intervention group
Group type: EXPERIMENTAL
Intervention: Betamethasone
Number of subjects: 59
Study 9386022 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 59
Study 8204703 — intervention group
Group type: EXPERIMENTAL
Intervention: UDCA 10 mg/kg/day for one year
Number of subjects: 90
Study 8204703 — intervention group
Group type: EXPERIMENTAL
Intervention: UDCA continued for three further months
Number of subjects: 90
Study 8204703 — intervention group
Group type: COMPARATOR
Intervention: Placebo after 12 months of UDCA
Number of subjects: 90
Study 3301452 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-acting propranolol, 160 mg once daily
Number of subjects: 19
Study 3301452 — intervention group
Group type: COMPARATOR
Intervention: Conventional propranolol, 40 mg three times daily
Number of subjects: 19
Study 29941495 — intervention group
Group type: EXPERIMENTAL
Intervention: Cholecalciferol (D3) 4,000 IU daily
Number of subjects: 2423
Study 29941495 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2423
Study 26678311 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose bexarotene plus PUVA
Number of subjects: 21
Study 23989505 — intervention group
Group type: EXPERIMENTAL
Intervention: Dental care program (complimentary care before and during oncological therapy)
Number of subjects: 46
Study 23989505 — intervention group
Group type: COMPARATOR
Intervention: Basic dental care (Control Group)
Number of subjects: 46
Study 23989505 — intervention group
Group type: EXPERIMENTAL
Intervention: Dental care program (TG)
Number of subjects: 46
Study 23838777 — intervention group
Group type: EXPERIMENTAL
Intervention: Heptavalent vaccine
Number of subjects: 421
Study 23838777 — intervention group
Group type: COMPARATOR
Intervention: Comparator vaccines
Number of subjects: 421
Study 21223755 — intervention group
Group type: EXPERIMENTAL
Intervention: Taxol plus Carboplatin (TP)
Number of subjects: 86
Study 21223755 — intervention group
Group type: COMPARATOR
Intervention: Gemcitabine plus Carboplatin (GP)
Number of subjects: 86
Study 18467717 — intervention group
Group type: EXPERIMENTAL
Intervention: Faxed patient/regimen-specific information
Number of subjects: 97
Study 18467717 — intervention group
Group type: COMPARATOR
Intervention: Usual correspondence
Number of subjects: 97
Study 17010792 — intervention group
Group type: EXPERIMENTAL
Intervention: 600 mg clopidogrel loading dose
Number of subjects: 292
Study 17010792 — intervention group
Group type: COMPARATOR
Intervention: 300 mg clopidogrel loading dose
Number of subjects: 292
Study 14613088 — intervention group
Group type: EXPERIMENTAL
Intervention: Model surgery performed with the aid of a robot arm
Number of subjects: 21
Study 14613088 — intervention group
Group type: COMPARATOR
Intervention: Manual model surgery
Number of subjects: 21
Study 11092418 — intervention group
Group type: EXPERIMENTAL
Intervention: Sexually stimulating primes
Number of subjects: 0
Study 11092418 — intervention group
Group type: COMPARATOR
Intervention: Neutral stimuli
Number of subjects: 0
Study 8831315 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold saline‐induced paresthesia
Number of subjects: 40
Study 8831315 — intervention group
Group type: COMPARATOR
Intervention: Nerve stimulator
Number of subjects: 40
Study 8831315 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 40
Study 1389822 — intervention group
Group type: EXPERIMENTAL
Intervention: methohexitone
Number of subjects: 96
Study 1389822 — intervention group
Group type: EXPERIMENTAL
Intervention: propofol
Number of subjects: 96
Study 1389822 — intervention group
Group type: EXPERIMENTAL
Intervention: thiopentone
Number of subjects: 96
Study 1389822 — intervention group
Group type: EXPERIMENTAL
Intervention: etomidate
Number of subjects: 96
Study 4025156 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose infusion of amrinone (200 micrograms/kg/hr for 30 minutes, 400 micrograms/kg/hr for 30 minutes and then 800 micrograms/kg/hr for 30 minutes)
Number of subjects: 22
Study 4025156 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose infusion of amrinone (800, 1,600 and 3,200 micrograms/kg/hr sequentially, each for 30 minutes)
Number of subjects: 22
Study 30180806 — intervention group
Group type: EXPERIMENTAL
Intervention: Tolvaptan treatment for 7 days
Number of subjects: 249
Study 30180806 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment for 7 days
Number of subjects: 249
Study 30180806 — intervention group
Group type: EXPERIMENTAL
Intervention: Tolvaptan treatment for 7 days in hyponatremia patients with resolved serum sodium
Number of subjects: 249
Study 30180806 — intervention group
Group type: EXPERIMENTAL
Intervention: Tolvaptan treatment for 7 days in hyponatremia patients with unresolved serum sodium
Number of subjects: 249
Study 24906836 — intervention group
Group type: EXPERIMENTAL
Intervention: Ayurvedic drugs (Mauktikyukta Kamdudha and Mauktikyukta Praval Panchamruta) during chemotherapy (Arm 1)
Number of subjects: 48
Study 24906836 — intervention group
Group type: EXPERIMENTAL
Intervention: Ayurvedic drugs (Mauktikyukta Kamdudha and Mauktikyukta Praval Panchamruta) after chemotherapy (Arm 2)
Number of subjects: 48
Study 24906836 — intervention group
Group type: EXPERIMENTAL
Intervention: Suvarnabhasmadi formulation in addition to MKD and MPP after chemotherapy (Arm 3)
Number of subjects: 48
Study 24906836 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy alone (Control group)
Number of subjects: 48
Study 22241101 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-visit website with question prompt sheet (QPS)
Number of subjects: 192
Study 22241101 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 192
Study 20334478 — intervention group
Group type: EXPERIMENTAL
Intervention: Erdosteine (triple therapy consisting of pantoprazole, amoxicillin, and clarithromycin plus erdosteine)
Number of subjects: 79
Study 20334478 — intervention group
Group type: COMPARATOR
Intervention: Placebo (triple therapy plus placebo)
Number of subjects: 79
Study 18361800 — intervention group
Group type: EXPERIMENTAL
Intervention: Aprotinin (500,000 IU after induction and repeat dose after chest closure)
Number of subjects: 59
Study 16418548 — intervention group
Group type: EXPERIMENTAL
Intervention: Foot reflexology (60 minutes, twice a week for five weeks)
Number of subjects: 59
Study 16418548 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 59
Study 16418548 — intervention group
Group type: EXPERIMENTAL
Intervention: Foot reflexology
Number of subjects: 59
Study 12917184 — intervention group
Group type: EXPERIMENTAL
Intervention: Patching
Number of subjects: 419
Study 12917184 — intervention group
Group type: COMPARATOR
Intervention: Atropine
Number of subjects: 419
Study 12917184 — intervention group
Group type: EXPERIMENTAL
Intervention: Patching (10 or more hours a day)
Number of subjects: 419
Study 12917184 — intervention group
Group type: EXPERIMENTAL
Intervention: Patching (less than 10 hours a day)
Number of subjects: 419
Study 10417464 — intervention group
Group type: EXPERIMENTAL
Intervention: suxamethonium 0.1 mg.kg‐1 intravenously
Number of subjects: 60
Study 10417464 — intervention group
Group type: COMPARATOR
Intervention: 0.9% sodium chloride (placebo)
Number of subjects: 60
Study 7473009 — intervention group
Group type: COMPARATOR
Intervention: Surgical debridement alone (DEBR)
Number of subjects: 7
Study 7473009 — intervention group
Group type: EXPERIMENTAL
Intervention: ePTFE membrane alone (G)
Number of subjects: 7
Study 7473009 — intervention group
Group type: EXPERIMENTAL
Intervention: ePTFE membrane plus root conditioning (G + D)
Number of subjects: 7
Study 7473009 — intervention group
Group type: EXPERIMENTAL
Intervention: ePTFE membrane plus root conditioning plus composite graft (G + D + B)
Number of subjects: 7
Study 1814457 — intervention group
Group type: EXPERIMENTAL
Intervention: Silver amalgam products (six different gamma‐2‐free types)
Number of subjects: 0
Study 1814457 — intervention group
Group type: EXPERIMENTAL
Intervention: Copalite
Number of subjects: 0
Study 1814457 — intervention group
Group type: EXPERIMENTAL
Intervention: High copper content silver amalgam products
Number of subjects: 0
Study 7053030 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture treatment
Number of subjects: 30
Study 7053030 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 30
Study 30819711 — intervention group
Group type: EXPERIMENTAL
Intervention: RT + HMB
Number of subjects: 156
Study 30819711 — intervention group
Group type: COMPARATOR
Intervention: RT + placebo
Number of subjects: 156
Study 30819711 — intervention group
Group type: COMPARATOR
Intervention: education + HMB
Number of subjects: 156
Study 30819711 — intervention group
Group type: COMPARATOR
Intervention: education + placebo
Number of subjects: 156
Study 27484436 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent treatment with vitamin K2 (45 mg/day) and risedronate (2.5 mg/day or 17.5 mg/week)
Number of subjects: 1874
Study 27484436 — intervention group
Group type: COMPARATOR
Intervention: Risedronate (2.5 mg/day or 17.5 mg/week) alone
Number of subjects: 1874
Study 27484436 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent treatment with vitamin K2 and risedronate
Number of subjects: 1874
Study 27484436 — intervention group
Group type: COMPARATOR
Intervention: Risedronate alone
Number of subjects: 1874
Study 25727583 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based vision screening test (WBT) VisionForKids.org
Number of subjects: 203
Study 25727583 — intervention group
Group type: COMPARATOR
Intervention: Electronic Visual Acuity (EVA) Tester
Number of subjects: 203
Study 24263075 — intervention group
Group type: EXPERIMENTAL
Intervention: 1‐legged helium‐hyperoxia (1L‐HH)
Number of subjects: 15
Study 24263075 — intervention group
Group type: COMPARATOR
Intervention: 1‐legged nitrogen‐hyperoxia (1L‐NH)
Number of subjects: 15
Study 22534814 — intervention group
Group type: EXPERIMENTAL
Intervention: Pralatrexate 190 mg/m on days 1 and 15 of a 28-day cycle
Number of subjects: 201
Study 22534814 — intervention group
Group type: COMPARATOR
Intervention: Erlotinib 150 mg/day
Number of subjects: 201
Study 22534814 — intervention group
Group type: EXPERIMENTAL
Intervention: Pralatrexate
Number of subjects: 201
Study 19173756 — intervention group
Group type: EXPERIMENTAL
Intervention: Noninvasive ventilation (NIV)
Number of subjects: 0
Study 17293707 — intervention group
Group type: EXPERIMENTAL
Intervention: Quetiapine addition to serotonin reuptake inhibitors
Number of subjects: 0
Study 17293707 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 15223203 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold pressor test condition (high-hostile men)
Number of subjects: 56
Study 15223203 — intervention group
Group type: COMPARATOR
Intervention: Non-cold pressor test condition (low-hostile men)
Number of subjects: 56
Study 11453610 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled beclomethasone
Number of subjects: 0
Study 11453610 — intervention group
Group type: COMPARATOR
Intervention: Inhaled beta agonists, theophylline, cromolyn, inhaled corticosteroids
Number of subjects: 0
Study 11453610 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral corticosteroids
Number of subjects: 0
Study 10938493 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose furosemide (500-1000 mg) plus hypertonic saline solution (HSS) infusion (150 ml of 1.4-4.6% NaCl) b.i.d.
Number of subjects: 60
Study 10938493 — intervention group
Group type: COMPARATOR
Intervention: High-dose furosemide (500-1000 mg) as a bolus b.i.d. without HSS.
Number of subjects: 60
Study 8794422 — intervention group
Group type: EXPERIMENTAL
Intervention: Matrix transdermal estradiol delivery system worn for 7 consecutive days
Number of subjects: 26
Study 8794422 — intervention group
Group type: COMPARATOR
Intervention: Reservoir transdermal patch worn for 4 days followed by another patch for 3 days
Number of subjects: 26
Study 1536785 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% 5-aminosalicylic acid (5-ASA) cream applied three times daily for up to 14 days
Number of subjects: 22
Study 1536785 — intervention group
Group type: COMPARATOR
Intervention: Placebo applied three times daily for up to 14 days
Number of subjects: 22
Study 6391735 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral mixed grass‐pollen vaccine
Number of subjects: 54
Study 6391735 — intervention group
Group type: COMPARATOR
Intervention: Matched placebo
Number of subjects: 54
Study 30895694 — intervention group
Group type: EXPERIMENTAL
Intervention: Purslane seeds (10 g/day) with low-calorie diet
Number of subjects: 54
Study 30895694 — intervention group
Group type: COMPARATOR
Intervention: Low-calorie diet
Number of subjects: 54
Study 29698955 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower serum uromodulin (tertile 1)
Number of subjects: 613
Study 29698955 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower serum uromodulin (tertile 1) after adjustment for confounding factors
Number of subjects: 613
Study 27423791 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidisciplinary supportive program (3-month duration, including three 60-min group classes, three 30-min peer support groups, and regular telephone follow-ups)
Number of subjects: 118
Study 27423791 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 118
Study 24799118 — intervention group
Group type: EXPERIMENTAL
Intervention: LED thermocured HVGIC
Number of subjects: 0
Study 24799118 — intervention group
Group type: COMPARATOR
Intervention: Composite resin
Number of subjects: 0
Study 24799118 — intervention group
Group type: COMPARATOR
Intervention: Glass-carbomer
Number of subjects: 0
Study 24799118 — intervention group
Group type: COMPARATOR
Intervention: Conventional HVGIC
Number of subjects: 0
Study 22672949 — intervention group
Group type: EXPERIMENTAL
Intervention: Positional Release Therapy (PRT)
Number of subjects: 30
Study 22672949 — intervention group
Group type: COMPARATOR
Intervention: Routine medical therapy
Number of subjects: 30
Study 20382717 — intervention group
Group type: EXPERIMENTAL
Intervention: Pleural ultrasound (PU)
Number of subjects: 44
Study 20382717 — intervention group
Group type: COMPARATOR
Intervention: Chest radiograph (CXR)
Number of subjects: 44
Study 18468831 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (8 mg single dose, intramuscular)
Number of subjects: 103
Study 18468831 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 103
Study 15816572 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil 0.3 microg kg(‐1)
Number of subjects: 90
Study 15816572 — intervention group
Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 90
Study 12020525 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin (1.5 g total dose over 5 days)
Number of subjects: 220
Study 12020525 — intervention group
Group type: COMPARATOR
Intervention: Vitamin C (1.5 g total dose over 5 days)
Number of subjects: 220
Study 12020525 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin
Number of subjects: 220
Study 12020525 — intervention group
Group type: COMPARATOR
Intervention: Vitamin C
Number of subjects: 220
Study 12020525 — intervention group
Group type: EXPERIMENTAL
Intervention: Albuterol inhaler
Number of subjects: 220
Study 10335749 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard error of measurement (SEM) applied to the Chronic Heart Failure Questionnaire (CHQ)
Number of subjects: 605
Study 10335749 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard error of measurement (SEM) applied to the SF-36
Number of subjects: 605
Study 8949472 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-day skills training for technical clinical skills
Number of subjects: 71
Study 8949472 — intervention group
Group type: EXPERIMENTAL
Intervention: Written test administered 1 month before and directly after the training
Number of subjects: 71
Study 8949472 — intervention group
Group type: EXPERIMENTAL
Intervention: Performance-based test
Number of subjects: 71
Study 8949472 — intervention group
Group type: EXPERIMENTAL
Intervention: Knowledge test score
Number of subjects: 71
Study 1718723 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnetic stimulation (MS) delivered 200 msec before S1
Number of subjects: 8